You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Chronic liver disease

Resmetirom for treating non-alcoholic steatohepatitis and liver fibrosis [ID6529]

  • In development
  • Reference number: GID-TA11414
  • Expected publication date:  10 June 2026
  • Project information
  • Project documents

On this page

  1. Declaration of interests
  2. Committee meetings
  3. Invitation to participate
  4. Referral
  5. Notes

Documents

Documents created during the development process.

Declaration of interests

  • Register of interests (MSWord 53 KB)

    Published:
    01 June 2026

Committee meetings

  • Committee meeting: 1

Invitation to participate

  • Final stakeholder list (PDF 134 KB)

    Published:
    10 July 2025
  • Equality impact assessment (scoping) (PDF 132 KB)

    Published:
    10 July 2025
  • Final scope (PDF 133 KB)

    Published:
    10 July 2025
  • NICE's response to comments on the draft scope and provisional stakeholder list (PDF 460 KB)

    Published:
    10 July 2025

Referral

  • Referral

Notes

  • Note

  • A Technical Engagement consultation took place with registered stakeholders. The Committee meeting was delayed to allow more time for this appraisal.

Back to top